Erickson Sederstrom Law Firm
General
Cases5
Challenger50%
Patent Owner50%
NPE50%
Practice Areas
BiotechMech Eng, ManufTransport., E-Comm.
Top Attorneys
Elite Ratings
DCTPTABCAFC
Analytics
Lawyers
Cases
Ratings Trends
Practice Areas
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 04/26/17 | ANSWER to 1 Complaint, Affirmative Defenses, And, COUNTERCLAIM against Novo Nordisk A/S, Novo Nordisk Inc. by Teva Pharmaceuticals USA, Inc..(Keller, Karen) (Entered: 04/26/2017) | |
| 03/13/17 | ORDER re 7 STIPULATION TO EXTEND TIME to Respond to the Complaint to April 26, 2017 filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Mary Pat Thynge on 3/13/17. (cak) (Entered: 03/13/2017) | |
| 03/13/17 | STIPULATION TO EXTEND TIME to Respond to the Complaint to April 26, 2017 - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) (Entered: 03/13/2017) | |
| 03/06/17 | SUMMONS Returned Executed by Novo Nordisk Inc., Novo Nordisk A/S. Teva Pharmaceuticals USA, Inc. served on 3/6/2017, answer due 3/27/2017. (Noreika, Maryellen) (Entered: 03/06/2017) | |
| 06/18/18 | NOTICE OF SERVICE of (1) Defendants First Amended Non-Infringement Contentions (2) Defendants Second Amended Invalidity Contentions (3) Tevas Supplemental Responses and Objections to Plaintiffs First Set of Interrogatories (Nos. 1-6) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) (Entered: 06/18/2018) | |
| 05/25/18 | STIPULATION TO EXTEND TIME for opening expert reports and rebuttal expert reports to July 13, 2018 and August 24, 2018, respectively - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Noreika, Maryellen) (Entered: 05/25/2018) | |
| 05/08/18 | STIPULATION TO EXTEND TIME for supplementations under Rule 26(e) and for the completion of fact witness depositions to June 15, 2018 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Noreika, Maryellen) (Entered: 05/08/2018) | |
| 05/04/18 | Letter to The Honorable Sherry R. Fallon from Maryellen Noreika regarding postponement of May 7, 2018 status conference. (Noreika, Maryellen) (Entered: 05/04/2018) | |
| 04/30/18 | NOTICE OF SERVICE of (1) Teva Pharmaceuticals USA, Inc.s Responses and Objections to Novo Nordisk and Novo Nordisk A/Ss Notice of Deposition under Federal Rule of Civil Procedure 30(b)(6) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) (Entered: 04/30/2018) | |
| 04/26/18 | MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, John Scheibeler, Ryan P. Johnson, Laura T. Moran, and So Yeon Choe - filed by Novo Nordisk A/S, Novo Nordisk Inc.. Motions referred to Sherry R. Fallon.(Noreika, Maryellen) (Entered: 04/26/2018) |